COVID-19 Risk Stratification
NCT04339387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1326
Last updated 2020-11-30
Summary
The investigators seek to derive and validate a clinically useful risk score for patients with Coronavirus Disease 2019 to aide clinicians in the safe discharge of patients.
Conditions
- Coronavirus
- Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2020-04-26
- Completion
- 2020-04-26
Countries
- United States
Study Locations
More Related Trials
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
NCT04371471 ·Status: COMPLETED
-
C-reactive Protein Levels Among Individuals With COVID-19
NCT04373798 ·Status: COMPLETED
-
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
NCT06055218 ·Status: COMPLETED
-
SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings
NCT06191393 ·Status: COMPLETED ·Phase: NA
-
Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients
NCT05201625 ·Status: UNKNOWN ·Phase: NA
-
Defining COVID-19 Infection Severity on Presentation to Hospital
NCT05677789 ·Status: UNKNOWN
-
COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics
NCT05892549 ·Status: RECRUITING
-
Outcomes in Hospitalized Older Patients With COVID-19
NCT04385212 ·Status: COMPLETED
-
SEVERITY SCORE FOR COVID-19 PNEUMONIA
NCT04372199 ·Status: UNKNOWN
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
NCT04409262 ·Status: COMPLETED ·Phase: PHASE3
-
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707 ·Status: COMPLETED
-
Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19)
NCT04365166 ·Status: UNKNOWN
-
Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
NCT04361032 ·Status: UNKNOWN ·Phase: PHASE3
-
Detecting Respiratory Viruses in Upper and Lower Respiratory Tract Samples
NCT01597089 ·Status: TERMINATED
-
Communities Fighting COVID-19!
NCT05148936 ·Status: COMPLETED ·Phase: NA
-
Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age
NCT04499300 ·Status: COMPLETED
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN
-
Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia
NCT04332913 ·Status: UNKNOWN
-
Developement and Evaluation of Serological Assays for COVID-19
NCT04377763 ·Status: UNKNOWN
-
Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis
NCT04331795 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Clinical Status Associated With Outcome Severity: An Unsupervised Machine Learning Approach
NCT05119465 ·Status: COMPLETED
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN
-
NoRCoRP Assessment Clinic
NCT04710836 ·Status: COMPLETED